Ajanta Pharma Ltd Quarterly Results

Q1 FY26-27 Results Summary

Revenue

The revenue stands at ₹1,625.96 crore, reflecting a quarter-on-quarter *(QoQ) increase of 14.37 per cent from ₹1,421.64 crore. This corresponds to a year-on-year *(YoY) growth of 24.82 per cent.

Operating Profit

Operating Profit stands at ₹423.58 crore, reflecting a quarter-on-quarter *(QoQ) increase of 27.04 per cent from ₹333.41 crore. This corresponds to a year-on-year *(YoY) growth of 20.56 per cent.

PBDT

PBDT stands at ₹491.30 crore, reflecting a quarter-on-quarter *(QoQ) increase of 25.18 per cent from ₹392.48 crore. This corresponds to a year-on-year *(YoY) growth of 31.92 per cent.

Profit Before Tax

Profit Before Tax stands at ₹446.80 crore, reflecting a quarter-on-quarter *(QoQ) increase of 28.72 per cent from ₹347.11 crore. This corresponds to a year-on-year *(YoY) growth of 34.93 per cent.

Net Profit

Net Profit stands at ₹334.22 crore, reflecting a quarter-on-quarter *(QoQ) increase of 25.32 per cent from ₹266.70 crore. This represents a 30.89 per cent year-on-year *(YoY) growth for the same year.

  • YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.

Ajanta Pharma Ltd Earnings

CategoryQ1 FY26-27Q1 FY25-26Change %FY25-26FY24-25Change %
Total Revenue1,625.961,302.6524.825,452.864,648.1017.31
Expenses1,202.38951.3026.394,058.033,388.6019.76
Other Income70.9026.33169.27172.0794.5082.08
Operating Profit423.58351.3520.561,566.901,354.0015.72
Depreciation44.5041.297.77173.14144.1120.14
Interest3.185.26-39.5416.1120.73-22.29
Profit Before Tax446.80331.1334.931,377.651,189.1615.85
Tax112.5875.7948.54300.08312.30-3.91
Net Profit334.22255.3430.891,056.00920.3914.73
CategoryQ1 FY26-27Q4 FY25-26Change %
Total Revenue1,625.961,421.6414.37
Expenses1,202.381,088.2310.49
Other Income70.9061.4315.42
Operating Profit423.58333.4127.04
Depreciation44.5045.37-1.92
Interest3.182.3634.75
Profit Before Tax446.80347.1128.72
Tax112.5880.4140.01
Net Profit334.22266.7025.32

Ajanta Pharma Ltd Research Reports

ActionTarget Price (₹)BrokerDateReports
Buy 3,145Motilal Oswal30-Dec-2025
Buy 3,250Edelweiss Securities04-Nov-2025
Buy 3,200Motilal Oswal29-Jul-2025
Accumulate 3,001Elara Capital02-May-2025
Accumulate 2,930Elara Capital31-Jan-2025

Ajanta Pharma Ltd Financial Reports

Data not available.

Ajanta Pharma Ltd Stock Prices Compare with Peers

Company1 Day1 Week1 Month3 Months6 Month1 Year
Ajanta Pharma0.17%1.19%3.95%18.13%24.89%40.03%
Anthem Bioscienc-0.60%-1.75%10.48%13.72%25.69%3.40%
Ipca Labs.0.37%9.71%5.74%15.51%28.78%39.95%
Gland Pharma0.25%-4.04%14.68%21.89%58.07%46.57%
Emcure Pharma-1.06%-3.06%-2.49%7.05%30.72%27.69%
Sai Life3.18%1.20%13.86%29.01%51.66%58.90%
Neuland Labs.1.30%0.38%23.87%40.31%71.40%69.87%

Ajanta Pharma Ltd Corporate Information

Chairman & Non Executive Dir.: Mannalal B Agrawal
Vice Chairman & Executive Dire: Madhusudan B Agrawal
ED / MD / Promoter: Yogesh Agrawal
ED / WTD / Joint MD / Promoter: Rajesh M Agrawal
Independent Non Exe. Director: David Rasquinha
Independent Non Exe. Director: Rajesh Shashikant Dalal
Independent Non Exe. Director: Medha Joshi
Independent Non Exe. Director: Simi Thapar
Senior Vice President & CS: Gaurang Shah

Ajanta Pharma Ltd News

No More Data

More